Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Explore various ways to make passive income without needing a traditional job. Discover opportunities to earn money effortlessly.
22,801 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A bold state move to end prediction markets triggers a rapid federal backlash. The ensuing lawsuit tests boundaries b...
Coinbase launches three new perpetual contracts that track MarketVector AI, Defense, and China indexes, giving trader...
Three fast-casual names—Chipotle, Cava Group, and Sweetgreen—sit at the center of today’s restaurant stock debate. Th...
Investing in memory chips means weighing volatility against opportunity. This article digs into could micron technolo...
When great news KLAC stock hits the headlines, investors want a clear game plan. This guide breaks down the potential...
NOWPayments launches a zero-fee, instant crypto payout platform built for high-volume partners, delivering 1-second s...
Variant has closed a $222 million fund to back early-stage startups at the intersection of AI, crypto, and autonomy. ...
Meme coins surge on social buzz, but lasting value requires more than hype. This guide examines whether pepe next dog...
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
A Sunrun co-founder disclosed the sale of 50,000 shares, prompting questions about timing and implications. This arti...